-
Loading metrics
Correction: Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example
- The PLOS ONE Staff
x
- Published: July 31, 2014
- https://doi.org/10.1371/journal.pone.0105179
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Loading metrics